NCT01806077View on ClinicalTrials.gov

Safety Study of PZ-128 in Subjects With Multiple Coronary Artery Disease Risk Factors

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions
Vascular DiseaseCoronary Artery Disease Risk Factors Multiple
Interventions
DRUG

PZ-128

Sequential single-dose escalation; 1 to 2 hour continuous intravenous infusion

Trial Locations (1)

21215

Sinai Hospital of Baltimore (Sinai Center for Thrombosis Research), Baltimore

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

collaborator

Sinai Hospital of Baltimore

OTHER

lead

Tufts Medical Center

OTHER

NCT01806077 - Safety Study of PZ-128 in Subjects With Multiple Coronary Artery Disease Risk Factors | Biotech Hunter | Biotech Hunter